Laboratory News and Research

RSS

Discovery could lead to new treatments for hypertension, dementia

A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

14 Jan 2020

Study may help develop new treatments for abnormal nerve growth in the spine

In experiments with genetically engineered and old mice, Johns Hopkins Medicine researchers say they have added to evidence that the vast majority of low back pain in people may be rooted in an overgrowth of pain-sensing nerves into spinal cartilaginous tissue.

14 Jan 2020

How SpatialOMx is Delivering New Insights into Disease Research

An interview with Shannon Cornett Ph.D, discussing the use of MALDI-guided spatial molecular analysis for biomarker discovery.

From Bruker Life Sciences Mass Spectrometry 14 Jan 2020

Researchers uncover genetic anomaly linked with poor response to common asthma treatment

A new Cleveland Clinic study has uncovered a genetic anomaly associated with poor response to a common asthma treatment.

13 Jan 2020

NAU scientists in search of a powerful combination of melanoma-fighting drugs

Melanoma is the most lethal type of skin cancer and unusually common in Arizona, where residents are exposed to higher-than-average amounts of ultraviolet radiation.

13 Jan 2020

Updated breast cancer guideline offers recommendations for handling cases with low ER expression

The updated guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer, published jointly today by the College of American Pathologists and the American Society of Clinical Oncology, reaffirms much of the original guidance and has more specific recommendations for handling and reporting cases with low ER expression.

13 Jan 2020

Study shows how insects adjust their physiological responses to gravity

If you jump out of bed too quickly, you might feel a bit light-headed. That's because when you're lying down, gravity causes your blood to pool in the lower parts of your body rather than in your brain.

13 Jan 2020

Blocking AHR receptor can reverse obesity, study finds

Obesity, a global epidemic, is a known contributor to several cancers, including breast, colon, and pancreatic. Stopping the obesity epidemic could be a critical aid in preventing and treating numerous cancers. Researchers with the laboratory of Craig Tomlinson, PhD, at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center have found a critical target in this cause.

13 Jan 2020

Study uncovers new subtypes of advanced pancreatic cancer

Researchers at the Ontario Institute for Cancer Research and the University Health Network have discovered detailed new information about the subtypes of pancreatic cancer. A better understanding of the disease groups may lead to new treatment options and improved clinical outcomes for this lethal disease.

13 Jan 2020

Leukemic cells are addicted to vitamin B6, research shows

Scientists have discovered that Acute Myeloid Leukemia (AML) grows by taking advantage of the B6 vitamin to accelerate cell division.

13 Jan 2020

Study shows link between lead exposure risk and brain structure in children

Though leaded gas and lead-based paint were banned decades ago, the risk of lead exposure is far from gone. A new study led by Elizabeth Sowell, PhD, shows that living in neighborhoods with high risk of lead exposure is associated with differences in brain structure and cognitive performance in some children.

13 Jan 2020

Researchers identify new pathway as biological target for colon cancer

Researchers have found a way to help make chemotherapy more effective in treating colon cancer. They identified a new pathway (RICTOR/mTORC2) as a biological target for the disease.

13 Jan 2020

New bacteria-destroying technology to combat drug-resistant superbugs

Researchers have used liquid metals to develop new bacteria-destroying technology that could be the answer to the deadly problem of antibiotic resistance.

13 Jan 2020

Scientists gain insights into structure and interactions of EGF receptors

Whether a cell grows, divides or dies is controlled among other things by receptors that messenger substances bind to externally.

13 Jan 2020

The Riney Family Multiple Myeloma Initiative to be established at Dana-Farber

Dana-Farber Cancer Institute will establish the Riney Family Multiple Myeloma Initiative to help improve outcomes and accelerate understanding of the underlying biology for the most challenging types of myelomas, cancers that form in a type of white blood cell called a plasma cell.

13 Jan 2020

A protein found in ovarian cancer may contribute to neurodegeneration in Alzheimer's disease

Houston Methodist scientists identified a protein found in ovarian cancer that may contribute to declining brain function and Alzheimer's disease, by combining computational methods and lab research.

13 Jan 2020

Mice study offers new insight on irritable bowel syndrome

Sometimes the end of an intestinal infection is just the beginning of more misery. Of those who contract traveler's diarrhea, for example, an unlucky few go on to develop irritable bowel syndrome (IBS), a chronic inflammation of the intestinal tract.

12 Jan 2020

Researchers discover how a new immune system works to protect bacteria from phages

Researchers at University of California San Diego School of Medicine have discovered how a new immune system works to protect bacteria from bacteriophages (phages), viruses that specifically infect bacteria.

11 Jan 2020

A molecular switch for repairing damage in central nervous system disorders discovered

A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis, Mayo Clinic researchers discovered.

11 Jan 2020

New tool judges accuracy of computer predictions of tumor’s genetic diversity

Cancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly susceptible or resistant to a given treatment. As a result, identifying these variations can help clinicians decide which treatment is most likely to be successful for a specific patient.

10 Jan 2020